MTOR and COVID-19: Metformin, an FDA-approved mTOR inhibitor, when administered as an anti-hyperglycemic drug in diabetes patients, was found to simultaneously act as an anti-hyperglycemic and antiviral agent (Lim et al., 2021), offering benefits in patients with COVID-19.